• The FDA approved Glaxosmithkline plc's Flulaval Quadrivalent (Influenza Virus Vaccine) for immunization of people older than 3 for seasonal influenza virus subtypes A and B. Flulaval is the London-based GSK's second intramuscular quadrivalent vaccine approved by the FDA.